The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk

Similar documents
LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

HCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.

Innovations in HCC Imaging: MDCT/MRI

Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece

Visualization of multistep hepatocarcinogenesis using various imaging biomarkers

Hyperplasia / Hypertrophy, Cirrhosis, Diagnostic procedure, MR, CT-Angiography, CT, Liver, Abdomen /ecr2012/C-2202

Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography

Hepatocellular carcinoma (HCC) is a malignant liver neoplasm

Imaging-Based Diagnostic Systems for Hepatocellular Carcinoma

Detection and Characterization of Hepatocellular Carcinoma by Imaging

Objectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma

Acknowledgements. Update of Focal Liver Lesions Goals. Focal Liver Lesions. Imaging Choices For Liver Lesions. Focal Liver Lesions

ACG Clinical Guideline: Diagnosis and Management of Focal Liver Lesions

Radiology of hepatobiliary diseases

Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe

Diagnostic efficacy of Gd-EOB-DTPA (Primovist)-enhanced MR imaging and CT for hepatocellular carcinoma

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases

CTA/MRA of Pediatric Hepatic Masses Radiology-Pathology Correlation

Financial Disclosure

Enhancements in Hepatobiliary Imaging:

: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l,

With the widespread use of hepatic imaging, liver masses

Objectives. LI-RADS v2017. Working Groups. Cynthia Santillan. Released October 2014 Diagnosis. Screening/ Surveillance. Diagnosis

Radiological Reasoning: Incidentally Discovered Liver Mass

Diagnostics guidance Published: 29 August 2012 nice.org.uk/guidance/dg5

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Key words: liver cirrhosis, hepatocellular carcinoma, nodular lesions mimicking hepatocellular carcinoma, multicentric carcinogenesis in liver

HEPATOCELLULAR CARCINOMA: SCREENING, DIAGNOSIS, AND TREATMENT

Multiple Primary Quiz

INTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2

US-Guided Radiofrequency Ablation of Hepatic Focal Lesions

Superparamagnetic Iron Oxide Enhanced Magnetic Resonance Images of Hepatocellular Carcinoma: Correlation With Histological Grading

Essentials of Clinical MR, 2 nd edition. 65. Benign Hepatic Masses

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

HEPATO-BILIARY IMAGING

Liver Tumors. Prof. Dr. Ahmed El - Samongy

State of the Art Imaging for Hepatic Malignancy: My Assignment

Paradoxical uptake of Gd-EOB-DTPA of focal hepatic nodule in the hepatobiliary phase

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

Tatsuo Inoue 1 Tomoko Hyodo. Yasuharu Imai 5 Atsushi Higaki. Kennichi Miyoshi 8 Masahiko Koda. Hironori Ochi 11 Masashi Hirooka

Hepatocellular carcinoma Cholangiocarcinoma. Jewels of hepatobiliary cancer imaging : what to look for? Imaging characteristics of HCC.

Liver Specific MRI using Gd-EOB-DTPA Disodium (Primovist) Effects Change in Management of Indeterminate Liver Lesions.

Gadoxetic Acid enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases

The Focal Hepatic Lesion: Radiologic Assessment

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiographyassisted CT) with special reference to multi-step hepatocarcinogenesis

The Incidental Focal Liver Lesion: Photon, Proton, or Needle?

Magnetic resonance imaging findings of hepatocellular carcinoma: typical and atypical findings

Introduction. Original Article

ADRENAL MR: PEARLS AND PITFALLS

New developments in liver MR imaging

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1

Gadoxetate Disodium Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology

HCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico

Cosmin Caraiani, 2,3 Liliana Chiorean, 1 Radu Badea 1. Introduction

AMSER Case of the Month: June 2018

Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging

The role of contrast enhanced ultrasound (ceus) in the assessment of liver nodules in patients with cirrhosis

Characterization of Incidental Liver Lesions: Comparison of Multidetector CT versus Gd-EOB-DTPA-Enhanced MR Imaging

Detection of Hypervascular Hepatocellular Carcinoma: Comparison of SPIO-enhanced MRI With Dynamic Helical CT

Review Article. Dig Dis 2015;33: DOI: /

American College of Radiology ACR Appropriateness Criteria

Diagnostic Challenges and Pitfalls in MR Imaging with Hepatocyte-specific

Biomedical Letters 2017 Volume 3 Issue 2 Pages 66-70

Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients

Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Contrast Agents for Liver MRI

Liver Cancer And Tumours

Surveillance for Hepatocellular Carcinoma

STANDARDIZED MANAGEMENT RECOMMENDATIONS FOR ADRENAL NODULES: EVIDENCE-BASED CONSENSUS POWERSCRIBE MACROS FROM AN ACADEMIC/PRIVATE PRACTICE

Gastrointestinal Imaging Original Research

Surveillance for HCC Who, how Diagnosis of HCC Surveillance for HCC in Practice

Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver

8/3/2016. Consultant for / research support from: Astellas Bayer Bracco GE Healthcare Guerbet Medrad Siemens Healthcare. Single Energy.


Timothy L. Miao 1, Ania Z. Kielar 2,3, Rebecca M. Hibbert 2, Nicola Schieda 2,3

CT/MRI LI-RADS v2017 CORE

The UGent Institutional Repository is the electronic archiving and dissemination platform for

Pseudo Washout Sign in High-Flow Hepatic Hemangioma on Gadoxetic Acid Contrast-Enhanced MRI Mimicking Hypervascular Tumor

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Multiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation

MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm

The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities

MRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA

Consensus Report of the Fifth International Forum for Liver MRI

CT Evaluation of the Progression of Hypoattenuating Nodular Lesions in Virus-Related Chronic Liver Disease

HCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation

HEPATOCYTE SPECIFIC CONTRAST MEDIA: WHERE DO WE STAND?

Focal Nodular Hyperplasia Like Nodules in Alcoholic Liver Cirrhosis: Radiologic Pathologic Correlation

Screening for Hepatoma and an Introduction to LIRADS

Liver Specialty Evening Conference. Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle

Radiation burden of hepatocellular carcinoma screening program in hepatitis B virus patients should we recommend magnetic resonance imaging instead?

ADRENAL LESIONS 10/09/2012. Adrenal + lesion. Introduction. Common causes. Anatomy. Financial disclosure. Dr. Boraiah Sreeharsha. Nothing to declare

Imaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma

Correspondence should be addressed to Masanori Matsuda;

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

Portal Venous Thrombosis: Tumor VS Bland Thrombus

Hepatocellular Carcinoma: Diagnosis and Management

Approach to Liver Lesions. Anjana A. Pillai, MD Associate Professor of Medicine Director, Liver Tumor Clinic The University of Chicago Medical Center

PEER-REVIEW REPORT CLASSIFICATION LANGUAGE EVALUATION SCIENTIFIC MISCONDUCT CONCLUSION. [ Y] Accept [ ] Grade B: Very good

Transcription:

2013 67 4 239 244 The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk Patients for Hepatocellular Carcinoma a* a,b a,c a a a a a a a a b c

240 67 4

2013 241 ʼ 56 38 67 9 18 32 1 70 53 83 69 53 83 71 57 83 0 35 41 15 29 9 12 6 0 52 49 5 1 1 33 4 0 1 16 1 1 0 0 40 12 0 2 0 383 4 11 2 2 0 91 1 20 2 2 5 383 4 0 40 3 0 5 0 0 27 0 0 0 0 0 27 0 0 5 0 0 0 5 0 21 24 10 166 22 10 81 26 13 166 0 30 105 67 63 8 38 36 2 12 6 20 12 6 20 12 6 19 0 47 78 74 3 47 70 1 31 81 6 0 20 3

242 67 4 1 2 78 74 3 16 20 42 7 71 33 34 11 28 40 10 26 50 2 77 73 3 15 20 42 7 70 33 33 11 28 39 10 26 49 2 1 1 0 1 0 0 0 1 0 1 0 0 1 0 0 1 0 11 10 5 4 3 4 1 10 6 4 1 5 4 2 3 8 0 8 7 6 2 3 3 1 7 4 3 1 2 4 2 2 6 0 3 2 9 2 0 1 0 3 2 1 0 3 0 0 1 2 0 16 15 2 8 4 4 5 11 3 7 6 5 7 4 2 13 1 95 105 78 74 3 65 2 81 7 92 71 77 2 67 6 84 6 76 62 81 6 71 4 88 7 31 26 83 9 67 4 92 9 64 55 85 9 75 4 92 4 29 26 89 7 73 6 96 4 23 21 91 3 73 2 97 6 21 21 100 74 5 100

August 2013 Diagnosis of Hypovascular HCC with EOB 243 Fig. 1 Typical findings of hypovascular hepatocellular carcinoma (HCC). A, T1-weighted enhanced MRI (arterial phase); B, Abdominal MRI (diffusion weighted image, b 1,000); C, Gd-EOB-DTPA-enhanced MRI (hepatobiliary phase); D, Abdominal ultrasonography; E, Histological finding of biopsied specimen (well-differetinated HCC). is inhibited in malignant liver lesions, such that they appear hypointense at the hepatobiliary phase [9]. Because so-called early HCCs do not show a classical HCC pattern, which is enhancement at an early arterial phase and washout at a portal venous phase, it is very difficult to distinguish them from other nonmalignant liver nodules by traditional imaging modalities. In the present study, we found that 74.3オ of hypovascular nodules that showed hypointensity at the hepatobiliary phase of EOB-MRI were HCCs. This PPV for the diagnosis of small hypovascular HCC is relatively high compared with other imaging modalities. Tajima. reported that only 9 of 19 (47オ) liver nodules showing hypoattenuation on CTHA were diagnosed as well-differentiated HCC [18]. Also, Hayashi. reported that 1 of 9 (11オ) liver nodules showing isoattenuation or hypoattenuation on CTHA and hypoattenuation on CTAP were diagnosed as well differentiated HCC [5]. Recently, other liver-specific contrast agents have been used, and those agents can also reveal hypovascular HCCs in some cases. Superparamagnetic iron oxide (SPIO) is a tissue-specific MR imaging contrast that is taken up by Kupffer cells in the liver; however, most of the well-differentiated HCCs had a similar number of Kupffer cells in the tumorous and nontumorous tissues. Therefore, it is difficult to distinguish dysplastic nodules from well-differentiated HCCs by SPIO-enhanced MR imaging alone [19]. Sonazoid is a lipid-stabilized suspension of perfluorobutane and is also taken up by the Kupffer cells. According to a recent report, only 3 of 13 (23.1オ) well-differentiated HCCs showed a perfusion defect in the Kupffer phase so that the diagnosis of hypovascular HCC by this method is also limited [20]. In our study, PPV of EOB-MRI at the hepatobiliary phase was high (74.3オ); however, the result is somewhat unsatisfactory because the false positive rate was 26オ. To achieve a higher PPV, we combined it with 3 independent factors: washout appearance at the delayed phase on triple-phase CT, the existence of a hypoechoic region in conventional US B-mode, and hyperintensity in DWI. As shown in Table 3, the PPV was raised to about 80オ when combined with one factor, and increased to almost 90オ when combined with 2 factors. When all 3 factors were positive, PPV reached 100オ. Liver biopsy for the diagnosis of HCC has several potential risks, such as intra-abdominal bleeding and the dissemination of tumor cells. The combination of examinations that we

244 67 4 1 2 3 4 5 6 7 8 1972 2001 2005 34 397 402 2004 127 27 34 1999 340 745 750 2002 225 143 149 1999 172 969 976 2005 42 27 34 1995 22 983 993 9 10 11 12 13 14 15 16 17 18 19 20 1996 111 1587 1592 1996 199 177 183 1996 200 59 67 2005 4 1 9 2 2011 21 1233 1242 2010 32 903 913 2010 20 2405 2413 2010 255 459 466 1995 195 785 792 1 3 2009 44 793 798 2002 178 885 897 2000 32 205 212 2009 44 733 741